Public Policy Resources

Advancements in biomarker testing have transformed cancer treatment, improving survival and quality of life by connecting patients with the therapies most likely to benefit them, and coverage is essential to ensuring access to precision treatments.

This white paper highlights the importance of state biomarker coverage laws and offers recommendations to expand access to testing.

Cancer patients need timely access to specialized providers, but limited networks can delay care, increase costs, and disrupt treatment.

The white paper explains how network adequacy affects access and offers policy solutions, and the infographic illustrates why stroong provider networks are essential.

Many cancer patients struggle to afford the cost of their prescription drugs and rely on copay assistance. Copay accumulator programs, however, prevent patients from fully benefiting from copay assistance.

This overview provides an introduction to copay accumulators, and this sample scenario illustrates how money moves under these programs.

Advances in medical devices have the potential to improve patient outcomes, reduce beneficiaries’ overall cost of care, and lower potential costs to the Medicare program. As cancer risk increases with age, it is critical to understand how the Centers for Medicare & Medicaid Services (CMS) ensures access to cutting-edge oncology technologies under Medicare – the primary insurer for individuals over 65. This paper analyzes Medicare’s coverage determination process and proposals to expedite beneficiaries’ access to new oncology technologies and presents policy recommendations for reform.

Health insurance coverage is essential for cancer prevention, diagnosis, treatment, and symptom management and is a strong indicator of cancer survival. 

This infographic shows the types of health coverage held by working-age Americans and cancer patients and survivors and provides a breakdown of the groups most likely to be uninsured.

Access to affordable, comprehensive health care coverage, which Affordable Care Act (ACA) coverage standards help to ensure, is crucial for cancer patients and survivors. Unfortunately, changes to the regulation of insurance have led to the proliferation of “junk plans” that are non-ACA compliant and pose a significant risk to beneficiaries.